Transoral electromyographic recordings in botulinum toxin-injected rat larynges

Annals of Otology, Rhinology and Laryngology

Volumn 106, Issue 11, 1997, Pages 956-964

  Inagi, Katsuhide ^a,c   Ford, Charles N ^a   Rodriquez, Arthur A ^a   Heisey, Dennis M ^b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c University of Wisconsin Health   (United States)

Author keywords

Anterior tibialis muscle; Botulinum toxin; Compound muscle action potential; Electromyography; Larynx; Rat; Thyroarytenoid muscle

Indexed keywords

BOTULINUM TOXIN;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DYSPHONIA; ELECTROMYOGRAM; INTRAMUSCULAR DRUG ADMINISTRATION; LARYNGOSCOPY; LARYNX MUSCLE; MALE; MUSCLE ACTION POTENTIAL; MUSCLE FUNCTION; NONHUMAN; PRIORITY JOURNAL; RAT; TIBIALIS ANTERIOR MUSCLE;

EID: 0030690525     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348949710601112     Document Type: Article

References (15)

1. Brown MC, Holland RL, Hopkins WG, Keynes RJ. An assessment of the signal for terminal sprouting within and between muscles. Brain Res 1980;210:145-51.
2. Shaari CM, Sanders I. Assessment of the biological activity of botulinum toxin. Therapy with botulinum toxin. New York, NY: Marcel Dekker, 1994:159-70.
3. Duchen LW. Changes in motor innervation and cholinesterase localization induced by botulinum toxin in skeletal muscle of the mouse: difference between fast and slow muscles. J Neurol Neurosurg Psychiatry 1970;33:40-54.
4. Cichon JV, McCaffrey TV, Litchy WJ, Knops JL. The effect of botulinum toxin type A injection on compound muscle potential in an in vivo rat model. Laryngoscope 1995;105:144-8.
5. Cohen SR, Thompson JW. Use of botulinum toxin to lateralize true vocal cords: a biochemical method to relieve bilateral abductor vocal cord paralysis. Ann Otol Rhinol Laryngol 1987;96:534-41.
6. George EF, Zimbler M, Wu B-L, Biller HF, Sanders I. Quantitative mapping of the effect of botulinum toxin injections in the thyroarytenoid muscle. Ann Otol Rhinol Laryngol 1992;101:888-92.
7. SAS Institute Inc. SAS/STAT user's guide, version 6. 4th ed. Vol 2. Cary, NC, 1989.
8. Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas 1960;20:37-46.
9. Inagi K, Ford CN, Bless DM, Heisey D. Analysis of factors affecting botulinum toxin results in spasmodic dysphonia. J Voice 1997;10:306-13.
10. Kobler JB, Datta S, Goyal RK, Benecchi EJ. Innervation of the larynx, pharynx, and upper esophageal sphincter of the rat. J Comp Neurol 1994;349:129-47.
11. Inagi K, Schultz E, Ford CN. An anatomical study of the rat larynx: establishing the rat model for neuromuscular research. Otolaryngol Head Neck Surg (in press).
12. Rosen M, Malmgren LT, Gacek RR. Three-dimensional computer reconstruction of the distribution of neuromuscular junctions in the thyroarytenoid muscle. Ann Otol Rhinol Laryngol 1983;92:424-9.
13. Claassen H, Werner JA. Fiber differentiation of the human laryngeal muscles using the inhibition reactivation myofibrillar ATPase technique. Anat Embryol (Berl) 1992;186: 341-6.
14. Valls-Sole J, Tolosa ES, Ribera G. Neurophysiological observation on the effects of botulinum toxin treatment in patients with dystonic blepharospasm. J Neurol Neurosurg Psychiatry 1991;54:310-3.
15. Oh SJ. Botulism: electrophysiological studies. Ann Neurol 1977;1:481-5.